Systematic review / meta-analysis / 2019
DHEA supplementation improved IVF/ICSI outcomes, including retrieved oocytes, pregnancy rate, and live birth rate, in women with DOR or POR.
A systematic review and meta-analysis of nine prospective RCTs involving 833 patients evaluated the efficacy of DHEA supplementation versus placebo during IVF or ICSI. DHEA treatment significantly increased the number of retrieved oocytes (mean difference: 0.91; 95% CI: 0.23-1.59; p = 0.009), the clinical pregnancy rate (RR: 1.27; 95% CI: 1.01-1.61; p = 0.04), and the live birth rate (RR: 1.76; 95% CI: 1.17-2.63; p = 0.006). No significant difference was observed for miscarriage rate (RR: 0.37; 95% CI: 0.12-1.13; p = 0.08).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 833 patients with diminished ovarian reserve and/or poor ovarian response undergoing IVF/ICSI (9 RCTs)
- What was measured
- Retrieved oocytes, clinical pregnancy rate, live birth rate, and miscarriage rate
THE PAPER
The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials.
Xu L, Hu C, Liu Q, Li Y. Geburtshilfe Frauenheilkd, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.